Healthcare provider profile · identity verified

Brian C. Derrick, D.O.

Internal Medicine · WENATCHEE, WA · NPI 1578573614

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	367	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	366	56
Atorvastatin Calcium	Atorvastatin Calcium	343	91
Losartan Potassium	Losartan Potassium	319	89
Omeprazole	Omeprazole	301	84
Gabapentin	Gabapentin	251	63
Metoprolol Succinate	Metoprolol Succinate	251	63
Rosuvastatin Calcium	Rosuvastatin Calcium	215	54
Amlodipine Besylate	Amlodipine Besylate	210	63
Levothyroxine Sodium	Levothyroxine Sodium	206	52
Potassium Chloride	Potassium Chloride	200	60
Metformin Hcl	Metformin Hcl	165	45
Tamsulosin Hcl	Tamsulosin Hcl	162	43
Albuterol Sulfate Hfa	Albuterol Sulfate	161	54
Furosemide	Furosemide	153	46
Hydrochlorothiazide	Hydrochlorothiazide	136	42
Oxycodone Hcl	Oxycodone Hcl	127	22
Trazodone Hcl	Trazodone Hcl	123	34
Simvastatin	Simvastatin	102	25
Tramadol Hcl	Tramadol Hcl	102	27
Baclofen	Baclofen	94	20
Meloxicam	Meloxicam	92	33
Pregabalin	Pregabalin	89	18
Glipizide	Glipizide	88	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	88	12
Carvedilol	Carvedilol	79	20
Methocarbamol	Methocarbamol	79	26
Ozempic	Semaglutide	77	14
Metoprolol Tartrate	Metoprolol Tartrate	76	24
Fluoxetine Hcl	Fluoxetine Hcl	69	18
Sertraline Hcl	Sertraline Hcl	69	18
Duloxetine Hcl	Duloxetine Hcl	68	16
Lovastatin	Lovastatin	68	20
Zolpidem Tartrate	Zolpidem Tartrate	67	12
Bupropion Hcl Sr	Bupropion Hcl	63	20
Spironolactone	Spironolactone	61	20
Allopurinol	Allopurinol	60	17
Bupropion Xl	Bupropion Hcl	60	16
Clopidogrel	Clopidogrel Bisulfate	59	13
Hydroxyzine Hcl	Hydroxyzine Hcl	59	13
Montelukast Sodium	Montelukast Sodium	58	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	15
Pravastatin Sodium	Pravastatin Sodium	55	18
Alendronate Sodium	Alendronate Sodium	51	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Lorazepam	Lorazepam	51	12
Ropinirole Hcl	Ropinirole Hcl	49	13
Prednisone	Prednisone	47	27
Fluticasone Propionate	Fluticasone Propionate	45	16
Metformin Hcl Er	Metformin Hcl	45	13
Morphine Sulfate Er	Morphine Sulfate	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Alprazolam	Alprazolam	41	14
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Torsemide	Torsemide	38	suppressed
Glipizide Er	Glipizide	37	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	17
Aripiprazole	Aripiprazole	35	suppressed
Azithromycin	Azithromycin	35	33
Donepezil Hcl	Donepezil Hcl	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Atenolol	Atenolol	34	suppressed
Finasteride	Finasteride	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	11
Clonazepam	Clonazepam	33	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Colchicine	Colchicine	30	12
Diclofenac Sodium	Diclofenac Sodium	30	12
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	20
Ipratropium Bromide	Ipratropium Bromide	29	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Prazosin Hcl	Prazosin Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Estradiol	Estradiol	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Topiramate	Topiramate	25	11
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Diazepam	Diazepam	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Eliquis	Apixaban	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Cephalexin	Cephalexin	20	17
Doxycycline Hyclate	Doxycycline Hyclate	20	15
Famotidine	Famotidine	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Digoxin	Digoxin	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Nitroglycerin	Nitroglycerin	18	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Tiotropium Bromide	Tiotropium Bromide	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Creon	Lipase/Protease/Amylase	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Nystatin	Nystatin	12	11
Oxycontin	Oxycodone Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Acyclovir	Acyclovir	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Flunisolide	Flunisolide	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error